Scientists have created embryonic stem cells in mice without destroying embryos in the process, potentially removing the major controversy over work in this field. Embryonic stem cells are special because they are pluripotent, meaning they can develop into virtually any kind of tissue type. They therefore offer the promise of customized cells for therapy.
The work, which appears in the June 6 online issue of Nature, was led by Rudolf Jaenisch, a member of the Whitehead Institute and a professor of biology at MIT. His colleagues on the work are from Whitehead, MIT, Massachusetts General Hospital, the Broad Institute of MIT and Harvard, and Harvard Medical School.
Somatic cell nuclear transfer ("therapeutic cloning") offers the hope of one day creating customized embryonic stem cells with a patient's own DNA. In this process, an individual's DNA would be placed into an egg, resulting in a blastocyst that houses a supply of stem cells. But to access these cells, researchers must destroy a viable embryo.
Now, Jaenisch and colleagues have demonstrated that embryonic stem cells can be created without eggs. By genetically manipulating mature skin cells taken from a mouse, the scientists transformed these cells back into a state identical to that of an embryonic stem cell. No eggs were used, and no embryos destroyed.
"These reprogrammed cells, by all criteria that we can apply, are indistinguishable from embryonic stem cells," says Jaenisch.
What's more, these reprogrammed skin cells can give rise to live mice, contributing to every kind of tissue type, and can even be transmitted via germ cells (sperm or eggs) to succeeding generations. "Germline transmission is the final and definitive proof that these cells can do anything a traditionally derived embryonic stem cell can do," adds Jaenisch.
"But," he cautions, "these results are preliminary and proof of principle. It will be a while before we know if this can ever be done in humans. Human embryonic stem cells remain the gold standard for pluripotent cells and it is a necessity to continue studying embryonic stem cells through traditional means."
In August 2006, researchers at Kyoto University reported that by activating four genes in a mouse skin cell, they could reprogram that cell into a pluripotent state resembling an embryonic stem cell. However, the resulting cells were limited when compared with real embryonic stem cells, and the Kyoto team was unable to generate live mice from these cells.
The Jaenisch team decided to replicate this experiment, while refining certain technical aspects. This group included Jaenisch lab postdocs Marius Wernig, Alexander Meissner and Tobias Brambrink, MIT graduate student Ruth Foreman, Manching Ku, a research fellow from Bradley Bernstein's lab at Massachusetts General Hospital, and Konrad Hochedlinger, formerly of the Jaenisch lab and now at Massachusetts General Hospital.
Using artificial viruses called vectors, the team activated the same four genes in a batch of mouse skin cells. These genes, Oct4, Sox2, c-Myc and Klf4, are called transcription factors, meaning that they regulate large networks of other genes. While Oct4 and Sox2 are normally active in the early stages of embryogenesis, they typically shut down once an embryo has developed beyond the blastocyst stage.
"We were working with tens of thousands of cells, and we needed to devise a precise method for picking out those rare cells in which the reprogramming actually worked," says Wernig. "On average, it only works in about one out of 1,000 cells."
To test for reprogramming, the team decided to zero in on Oct4 and another transcription factor called Nanog. These two hallmarks for embryonic stem cell identity are only active in fully pluripotent cells. The trick would be to figure out a way to harvest Oct4- and Nanog-active cells from the rest of the population.
The answer came in the form of a laboratory technique called homologous recombination. Here, the scientists took genetic material known to be resistant to the toxic drug neomycin and spliced it into the genomes of each cell right beside Oct4 and Nanog. If Oct4 and Nanog switched on, the drug-resistant DNA would also spring into action. The researchers then added neomycin to the cells. Only those fully reprogrammed cells with active Oct4 and Nanog survived.
Next, the team ran these cells through a battery of tests, seeing if they could discover any substantial differences between these cells and normal embryonic stem cells.
"In all tests...there were no molecular markers distinguishing these two groups," says Meissner.
But definitive proof would only come through demonstrating that these cells could actually develop into any kind of body tissue and cell type. The researchers approached this question in three ways.
First, they fluorescently labeled these reprogrammed cells and injected them into early-stage embryos, which eventually gave rise to live mice. While these mice consisted of both the reprogrammed cells and the natural cells from the original embryo, the fluorescent tags indicated that the reprogrammed cells contributed to all tissue types in the mouse, everything from blood to internal organs to hair color.
Next, they bred these mice and found lineages of the reprogrammed cells in the subsequent generation, proving that these new cells had contributed to the germ line.
Finally, the team took advantage of another lab technique that involves creating a genetically abnormal embryo whose cells all consist of four chromosomes, rather than two. Because of this aberrant formation, the embryo can only form a placenta and cannot develop into a full-term fetus. The researchers injected the reprogrammed cells into this embryo and then implanted it in a uterus. Eventually live late-gestation fetuses could be recovered--created exclusively from the reprogrammed cells.
"This is the most stringent criteria anyone can use to determine if a cell is pluripotent," says Jaenisch.
Still, many technical hurdles remain for possibly translating this work to human cells. For example, the homologous recombination technique used to isolate the pluripotent cells does not yet work in human embryonic stem cells.
"We are optimistic that this can one day work in human cells," says Wernig. "We just need to find new strategies to reach that goal. For now, it would simply be premature and irresponsible to claim that we no longer need oocytes for embryonic stem cell research."
This research is supported by the National Institutes of Health.
A version of this article appeared in MIT Tech Talk on June 13, 2007 (download PDF).
Continue reading here:
- Global Human Embryonic Stem Cells Market 2020 to Witness Huge Growth by 2026 | Top Key Players; Lonza Group Ltd., Life Technologies Corporation,... - September 28th, 2020
- Stem Cell Market Potential Growth, Size, Share, Demand and Analysis of Key Players Research Forecasts to 2027 - The Daily Chronicle - September 28th, 2020
- Hair loss treatment: Breakthrough research links one ingredient to hair growth - Express - September 28th, 2020
- Cell Freezing Media for Cell Therapy Market To Witness Growth Acceleration Duri - News by aeresearch - September 28th, 2020
- Stem Cell Characterization and Analysis Tool Market Share, Sales Channels and Overview Till 2025 - The Research Process - September 26th, 2020
- Human Embryonic Stem Cells (HESC) Market is Expected to Witness Significant Growth-Says QYResearch | , ESI BIO, Thermo Fisher, BioTime, MilliporeSigma... - September 20th, 2020
- Species-specific pace of development is associated with differences in protein stability - Science Magazine - September 20th, 2020
- The Fascinating Story of Q Stock BioRestorative Therapies Inc (OTCMKTS: BRTXQ) - MicroCap Daily - September 20th, 2020
- Global Stem Cell Therapy Market 2020 Research on Import-Export Details, Business Standards and Forecast to 2025 - Scientect - September 16th, 2020
- Insights Into the Structure and Function of the Immortality Protein - Technology Networks - September 15th, 2020
- Global Cell Freezing Media for Cell Therapy Industry Report 2020 History, Present and Future - Express Journal - September 15th, 2020
- Patenting Stem Cell Inventions in India- What to Expect? - Lexology - September 11th, 2020
- Stem Cell Banking Market will Hit Big Revenues in Future | COVID19 Unlock opportunities - The Daily Chronicle - September 11th, 2020
- Novel discovery could lead to stem cell-based treatment for heart failure - News-Medical.Net - September 11th, 2020
- Global Stem Cells Market Report, History And Forecast 2020-2027, Breakdown Data By Manufacturers, Key Regions, Types And Application - Bulletin Line - September 11th, 2020
- Global Stem Cell Reconstructive Market- Industry Analysis and Forecast (2020-2027) - Kewaskum Statesman News Journal - September 11th, 2020
- Development Trends and Financial Analysis of Stem Cell Assay Market - The Daily Chronicle - September 11th, 2020
- School of Science grows by 10 - MIT News - September 8th, 2020
- Stem Cell Therapy Market to Fuel Revenues Through 2020 Lake Shore Gazette - Lake Shore Gazette - September 8th, 2020
- Kerala's KK Shailaja tops as women dominate top 10 of Prospect's 'thinkers for the COVID-19 age' list - The New Indian Express - September 8th, 2020
- Cell Therapy Manufacturing Market to be Worth USD 8 billion by 2030, predicts Roots Analysis - Scientect - September 8th, 2020
- Live-cell imaging and analysis reveal cell phenotypic transition dynamics inherently missing in snapshot data - Science Advances - September 8th, 2020
- An ancient virus might have made our hearts bigger - Scope - Scope - September 8th, 2020
- How Groups of Cells Cooperate to Build Organs and Organisms - The Scientist - September 3rd, 2020
- Study reveals genetic mutations may be linked to infertility, early menopause - Sify News - September 3rd, 2020
- Practical Problems with Embryonic Stem Cells | USCCB - August 29th, 2020
- Foetal cells are used to make the Oxford coronavirus vaccine. But they came from a foetus in 1973 - ABC News - August 29th, 2020
- Global Stem Cell Reconstructive Market- Industry Analysis and Forecast (2020-2027) - Galus Australis - August 29th, 2020
- Translational Regenerative Medicines Market: Which Region Will Register Higher CAGR? 2017-2026 - Scientect - August 29th, 2020
- Stem Cell Therapy Market: Trends, Applications, Industry Competitive Analysis, Growth,Forecast: 2019 to 2029 - The Scarlet - August 29th, 2020
- Cellular Reprogramming Tools Market 2020 (Covid-19 Impact) In-depth Industry Analysis By Types, Applications and Forecast 2026: Celgene, Cynata,... - August 27th, 2020
- Pro-life groups applaud Trump administration advisory board for rejecting fetal tissue research proposals - Christianity Daily - August 27th, 2020
- Global regenerative medicine market size was USD 23841.5 Million in 2018 and is Projected to Reach USD 151949.5 Million by 2026, Exhibiting a CAGR of... - August 27th, 2020
- Archbishops vaccine stance out of tune with community - The Age - August 27th, 2020
- Cellular Reprogramming Tools Market- By Type, Component, Industry, Region Market Size, Demand Forecasts, Company Profiles, Industry Trends and... - August 22nd, 2020
- Stem Cell Therapy Market by Treatment,Application,End Users and Geography Forecast To 2026 - Good Night, Good Hockey - August 22nd, 2020
- Global Stem Cells Market Report Forecast to 2025 by Global Market Insights, Key Companies and Driving Trends| CCBC, Vcanbio, Boyalife, Beikebiotech -... - August 20th, 2020
- Ron Evans steals a trick from I/O, and points the way to a transformational diabetes therapy - Endpoints News - August 20th, 2020
- AgeX Therapeutics Reports Second Quarter 2020 Financial Results and Provides Business Update - Stockhouse - August 20th, 2020
- Stem Cell Therapy Market Landscape Assessment By Type and Analysis Current Trends by Forecast To 2025 - The Daily Chronicle - August 19th, 2020
- Stem Cell Therapy Market Size By Product Analysis, By Application, By End-Users, By Regional Outlook, By Top Companies and Forecast to 2027 - Bulletin... - August 19th, 2020
- Stem Cell Therapy Market Size and Growth By Leading Vendors, By Types and Application, By End Users and Forecast to 2027 - Bulletin Line - August 19th, 2020
- ASU engineers get to the heart of organs-on-a-chip - ASU Now - August 19th, 2020
- Cell Isolation/Cell Separation Market Research Report by Product, by Cell Type, by Cell Source, by Technique, by Application, by End User - Global... - August 16th, 2020
- What Are the Five Warning Signs of Testicular Cancer? - MedicineNet - August 16th, 2020
- Stem Cell Banking Market Industry Analysis & Forecast (2019-2026) by Type, Service, Application and Geography. - Good Night, Good Hockey - August 13th, 2020
- Human Embryonic Stem Cells market to see major growth by 2026 | Lonza Group Ltd., Life Technologies Corporation, NuVasive Inc., TiGenix NV, Sumanas,... - August 11th, 2020
- New Study Presents Cell-based Therapy for MN Diseases or Spinal Cord Disorders - Mirage News - August 11th, 2020
- How Close Are We To Making Babies from Bone Marrow? - Discover Magazine - August 11th, 2020
- H.C. Wainwright Keeps Their Buy Rating on Lineage Cell Therapeutics (LCTX) - Smarter Analyst - August 7th, 2020
- Global Stem Cell Reconstructive Market- Industry Analysis and Forecast (2020-2027)-by Sources, Cell Type, Application, End User and Region. - WOLE TV - August 5th, 2020
- The Trouble With CRISPR The Strand - Strand - August 5th, 2020
- Global Stem Cell Reconstructive Market- Industry Analysis and Forecast (2020-2027)-by Sources, Cell Type, Application, End User and Region. - Red... - July 30th, 2020
- Human Embryonic Stem Cells (HESC) Market Growth by Top Companies, Trends by Types and Application, Forecast to 2026|ESI BIO, Thermo Fisher, BioTime -... - July 30th, 2020
- Waveguide Combiners & Dividers Market 2020 Global Share, Growth, Size, Opportunities, Trends, Regional Overview, Leading Company Analysis, And Key... - July 30th, 2020
- Expanded encyclopaedias of DNA elements in the human and mouse genomes - Nature.com - July 30th, 2020
- Global Stem Cell Therapy Market 2020 Analysis by Geographical Regions, Type and Application Till 2027 - Market Research Posts - July 30th, 2020
- New model may explain why certain cancer cells are resistant to therapy - News-Medical.Net - July 30th, 2020
- "Self-eating" Process of Stem Cells May be Key to New Regenerative Therapies - Mirage News - July 28th, 2020
- Stem Cell Characterization and Analysis Tool Market 2020 Report Forecast By Global Industry Trends, Future Growth, Regional Overview - Express Journal - July 28th, 2020
- Researchers Discover a New Side of Cancer that May Explain Its Resistance to Treatment - Genetic Engineering & Biotechnology News - July 28th, 2020
- Letters to editor: Sundial Bridge gathering, Donald Trump and COVID-19 - Record Searchlight - July 28th, 2020
- Stem Cell Therapy Market to Surpass US$ 40.3 Billion by 2027, Owing to Increasing Incidence of Spina - PharmiWeb.com - July 24th, 2020
- 'Embryoids' not the breakthrough they're made out to be - The B.C. Catholic - July 24th, 2020
- Genetic puzzle: How mice can be modified to help in the race to develop coronavirus therapies - Genetic Literacy Project - July 24th, 2020
- What's next for Tony Fauci, if the White House continues to sour on him? - STAT - July 16th, 2020
- Stem Cell Characterization and Analysis Tool Market 2020-2026 | Comprehensive Study of COVID-19 Impact | Worldwide Key Players: Osiris Therapeutics,... - July 14th, 2020
- Turning off junk DNA may free stem cells to become neurons - National Institutes of Health - July 14th, 2020
- Why are scientists trying to manufacture organs in space? - Space.com - July 14th, 2020
- Stem Cell Characterization and Analysis Tool Market Growth, Size, Opportunities and Analysis Forecast 2020 - 3rd Watch News - July 14th, 2020
- What Miniature Lab-Grown Brains Reveal About the Effects of Covid-19 - OneZero - July 14th, 2020
- Transdermal Testosterone Market Size By Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies And Forecast Up To 2026 -... - July 14th, 2020
- Impact Analysis of COVID-19 on Stem Cells Market Study 2018-2028 Segmented On The Basis of Product Type, Geographical Analysis, Future Forecast,... - July 11th, 2020
- COVID-19 Impact and Recovery Analysis on Cell Freezing Media for Cell Therapy Market 2020-2026 by BioLife Solutions, Akron Biotechnology, GE... - July 11th, 2020
- Stem Cell Therapy Market : Global Forecast over 2025 Cole of Duty - Cole of Duty - July 10th, 2020
- Stem Cells Market Emerging Trends, Business Opportunities, Segmentation, Production Values, Supply-Demand, Brand Shares and Forecast 2020-2027 - Cole... - July 10th, 2020
- Human Embryonic Stem Cells (HESC) Market Growth By Manufacturers, Type And Application, Forecast To 2026 - 3rd Watch News - July 10th, 2020
- Human CNS barrier-forming organoids with cerebrospinal fluid production - Science Magazine - July 10th, 2020
- Why we still haven't cloned humans it's not just ethics - Business Insider - Business Insider - July 10th, 2020
- Network Traffic Analyzer Market Size 2020 Global Industry Insights, Share, Growth, Trend, Demand, Top Players, Opportunities and Forecast to 2025 -... - July 10th, 2020